ŷAV

Phishing warning 01-May-2024
We are aware of phishing emails targeting speakers of events whose names appear on our events pages. If you are unsure if an email regarding event registration or accommodation has come from us please contact us and do not provide any credit card details or personal information.

3rd Annual Formulation & Drug Delivery USA Congress

17 March 2020 07:30 - 18 March 2020 17:00, CA, United States


Introduction
Over 300 delegates representing leading pharmaceutical organisations, biotech companies internationally renowned research & academic institutions will be present

Over 55 case studies and presentations focused on exploring challenges and solutions in formulation and drug delivery of small and large molecules. This includes the latest strategies for optimizing pharmaceutical formulations, new drug delivery systems including nano & RNA delivery, Quality by Design for continuous manufacturing and processing, and the bioanalysis, characterisation and stabilisation of drug products

  *Six highly interactive streams:*
  • Innovation In Large Molecule Drug Development
  • Small Molecule Drug Delivery
  • NEW! Continuous Manufacturing, CMC and Process Development
    • Featured Session: Cell & Gene Therapy Delivery
  • Small Molecule Drug Formulation
  • Advances in Large Molecule Drug Delivery
  • NEW! Bioanalysis, Characterization & Stabilization
    • Featured Session: Nano & RNA Delivery & Formulation
  *View Agenda: http://bit.ly/2ls5tnH*

Co-located with the 3rd Annual Inhalation & Respiratory Drug Delivery USA Congress.

For more information contact g.alonso@oxfordglobal.co.uk.

Go Social: Join our Formulation & Drug Delivery Network on LinkedIn, follow us on Twitter @FDDCongress & join the conversation at #FDDUS19
 
  *2019 Live Webinars*
“Understanding Supersaturation Of Small Molecule To Improve Oral Bioavailability” 
Sudhakar Garad, Global Head of Chemical and Pharmaceutical Profiling, Novartis Institutes for BioMedical Research 
5th February 2020, 09.30am EST/14.30pm UK Time.
  *Register for Free: https://bit.ly/2jW6Ev9
 
“Ocular biopharmaceutics: impact of modeling and simulation on topical ophthalmic formulation development”
Hovik Gukasyan, Associate Director, Early Development Formulation and Physical Chemistry, Allergan
12th February 2020, 08.00am EST/16.00pm UK Time. 
  *Register for Free: https://bit.ly/2ls6Y5j*

Useful links

Speakers
  • Kerstin Walke, Vice President of Pharmaceutical Development, Boehringer Ingelheim, United Kingdom
  • Anand Subramony, Vice President, External Innovation and Novel Technologies, AstraZeneca, United Kingdom
  • Sushrut Kulkarni, Group Vice President – Formulation & CMC, Glenmark Pharmaceuticals, United Kingdom
  • Marian Gindy, Executive Director, Pharmaceutical Sciences, MSD, United Kingdom
  • Evgenyi Shalaev, Executive Director, Pharmaceutical Development, Allergan, United Kingdom

Venue
Hilton San Diego Mission Valley

Hilton San Diego Mission Valley, 901 Camino del Rio South,, San Diego, CA, 92108, United States

Useful links

Organised by

Contact information
Search
 
 
Showing all upcoming events
Start Date
End Date
Location
Subject area
Event type

Advertisement
Spotlight


E-mail Enquiry
*
*
*
*